Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2023.02.09.527464v1?rss=1
Authors: Vera Gonzalez, J., Eberhardt, M., Lischer, C., Weich, A.
Abstract: Tumor-associated antigens (TAAs) and their derived peptides constitute the chance to design off-the-shelf mainline or adjuvant anti-cancer immunotherapies for a broad array of patients. Here, we present a computational pipeline that selects and ranks candidate antigens in a multi-pronged approach and applied it to the case of uveal melanoma. In addition to antigen expression in the tumor target and in healthy tissues, we incorporated a network analysis-derived antigen indispensability index motivated by computational modeling results, and candidate immunogenicity predictions from a machine learning ensemble model on peptide physicochemical characteristics.
Copy rights belong to original authors. Visit the link for more info
Podcast created by Paper Player, LLC